Medidata Solutions Inc. (MDSO)

70.01
0.81 1.10
NASDAQ : Technology Services
Prev Close 70.82
Open 70.38
Day Low/High 69.10 / 71.47
52 Wk Low/High 59.60 / 88.87
Volume 986.25K
Avg Volume 684.40K
Exchange NASDAQ
Shares Outstanding 59.68M
Market Cap 4.13B
EPS 0.80
P/E Ratio 78.72
Div & Yield N.A. (N.A)
Medidata Reports Third Quarter 2018 Results

Medidata Reports Third Quarter 2018 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018.

Medidata To Host Investor Day On October 24 In New York

Medidata To Host Investor Day On October 24 In New York

Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York.

Medidata Cloud Securely Manages Echocardiogram Images For Global Heart Measurement Study

Medidata Cloud Securely Manages Echocardiogram Images For Global Heart Measurement Study

Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World Alliance of Societies of Echocardiography (WASE) Normal Values Study.

(Graphic: Business Wire)

(Graphic: Business Wire)

More than 15,000 studies have been conducted on the Medidata Cloud, the Intelligent Platform for Life Sciences, Medidata (NASDAQ: MDSO) announced today, making it the industry's largest data repository.

Medidata Announces Third Quarter 2018 Earnings Conference Call

Medidata Announces Third Quarter 2018 Earnings Conference Call

Medidata (NASDAQ: MDSO) today announced that it will release its third quarter 2018 financial results before the market opens on Thursday, October 18, 2018.

Medidata And Decibel Therapeutics Announce Multi-Year Collaboration In Support Of Clinical Development For Hearing Loss, Tinnitus, And Balance Disorders

Medidata And Decibel Therapeutics Announce Multi-Year Collaboration In Support Of Clinical Development For Hearing Loss, Tinnitus, And Balance Disorders

Medidata (NASDAQ:MDSO) today announced that Decibel Therapeutics is adopting Medidata Cloud, the Intelligent Platform for Life Sciences.

Medidata Certified As A Great Place To Work®

Medidata Certified As A Great Place To Work®

Medidata employees take great pride as "Medidatians," according to the 2018 Great Place to Work® survey.

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.

Hanmi To Streamline Clinical Trials And Bolster Quality Of Results With Medidata Cloud

Hanmi To Streamline Clinical Trials And Bolster Quality Of Results With Medidata Cloud

Hanmi expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to improve clinical trial efficiency and quality of results, Medidata (NASDAQ:MDSO) announced today.

Medidata Selected For Fortune 100 Fastest-Growing Companies List

Medidata Selected For Fortune 100 Fastest-Growing Companies List

In recognition of three record-performing years, Medidata (NASDAQ: MDSO) was selected for Fortune's 100 Fastest-Growing Companies list.

Medidata Corporate Social Responsibility Initiatives Benefit Patients, Students, And Communities

Medidata Corporate Social Responsibility Initiatives Benefit Patients, Students, And Communities

Making a difference in the lives of patients and the global community is in Medidata's (NASDAQ:MDSO) DNA.

Medidata Reports Second Quarter 2018 Results

Medidata Reports Second Quarter 2018 Results

Medidata (NASDAQ: MDSO) today announced its financial results for the second quarter of 2018.

Novartis Partners With SHYFT To Support Its Digital Transformation

Novartis Partners With SHYFT To Support Its Digital Transformation

SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, announced today that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe.

Medidata NEXT Seoul And Shanghai Events Host Industry Thought Leaders At The Forefront Of The Digital Transformation In Life Sciences

Medidata NEXT Seoul And Shanghai Events Host Industry Thought Leaders At The Forefront Of The Digital Transformation In Life Sciences

This week, the Asia Pacific segment of Medidata's (NASDAQ:MDSO) global NEXT series continues with customer events in Seoul and Shanghai.

Medidata Schedules Second Quarter Earnings Conference Call For July 24, 2018

Medidata Schedules Second Quarter Earnings Conference Call For July 24, 2018

Medidata (NASDAQ:MDSO), today announced that it will release its second quarter 2018 financial results before the open of the market on Tuesday, July 24, 2018.

Medidata Appoints New China GM And Doubles Size Of Talent In Region

Medidata Appoints New China GM And Doubles Size Of Talent In Region

With China based customers doubling in 2017, Medidata (NASDAQ: MDSO) announced the appointment of Jim (Hui) Xu as general manager in the market, and plans to double the size of local talent.

Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden With Medidata

Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden With Medidata

To make clinical research truly patient-centric, Medidata (NASDAQ: MDSO) announced the launch of the Patient Burden Index (PBI) on the Medidata Cloud, the Intelligent Platform for Life Sciences.

The Intelligent Platform For Life Sciences (Graphic: Business Wire)

The Intelligent Platform For Life Sciences (Graphic: Business Wire)

Medidata (NASDAQ:MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.

Major Cancer Center Further Advances Oncology Research By Integrating Genomic Data Into Medidata's EClinical Platform

Major Cancer Center Further Advances Oncology Research By Integrating Genomic Data Into Medidata's EClinical Platform

Medidata (NASDAQ: MDSO) announced that Memorial Sloan Kettering Cancer Center (MSK) is using Rave Omics with Biomarker Discovery for patients with pancreatic cancer, an example of the paradigm shift in clinical trials through the systematic capture of...

Medidata To Showcase Rave Omics With Biomarker Discovery In Oncology Research At Industry Expert Theater Presentation

Medidata To Showcase Rave Omics With Biomarker Discovery In Oncology Research At Industry Expert Theater Presentation

For the second consecutive year, Medidata (NASDAQ:MDSO) will be presenting its pioneering analytics innovation during the 2018 ASCO Annual Meeting.

PhaseBio Pharma Becomes Medidata's 1,000th Customer, Making Company First In Industry To Achieve This Milestone

PhaseBio Pharma Becomes Medidata's 1,000th Customer, Making Company First In Industry To Achieve This Milestone

Biotech company, PhaseBio Pharmaceuticals, has become Medidata's (NASDAQ:MDSO) 1,000th customer.

Medidata Holds Global Heart Health Awareness Week To Encourage Employee Wellness

Medidata Holds Global Heart Health Awareness Week To Encourage Employee Wellness

Heart disease is the leading cause of death for both men and women. In partnership with the American Heart Association, Medidata (NASDAQ:MDSO) is holding its first annual 'Global Heart Health Awareness' week to provide employees around the world with...

Medidata To Present At The 46th Annual J.P. Morgan Global Technology, Media And Communication Conference

Medidata To Present At The 46th Annual J.P. Morgan Global Technology, Media And Communication Conference

Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, will present at the 46th Annual J.

Medidata Offers Breakthrough To De-Risk Clinical Trial Submissions

Medidata Offers Breakthrough To De-Risk Clinical Trial Submissions

To help organizations mitigate the risk of regulatory non-approval and delays, Medidata Solutions (NASDAQ:MDSO) is transforming how clinical trial data is validated prior to FDA submission with Edge Trial Assurance.

Medidata's Melinda Pautsch Named A "Rising Star" By The Healthcare Businesswomen's Association

Medidata's Melinda Pautsch Named A "Rising Star" By The Healthcare Businesswomen's Association

Medidata (NASDAQ: MDSO) is pleased to announce that its director of strategic accounts and medical device/diagnostic sales, Melinda Pautsch, has been named a 2018 "Rising Star" by the Healthcare Businesswomen's Association (HBA).

Medidata To Present At Jefferies 2018 Global Technology Conference

Medidata To Present At Jefferies 2018 Global Technology Conference

Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2018 Global Technology Conference on Wednesday, May 9, 2018, at 2:30 p.

Idera Pharmaceuticals Increases Operational Efficiency Of Global Oncology Program With Medidata Clinical Cloud

Idera Pharmaceuticals Increases Operational Efficiency Of Global Oncology Program With Medidata Clinical Cloud

Medidata (NASDAQ:MDSO) today announced that Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), expanded its use of the Medidata Clinical Cloud® to automate operations, increase efficiencies, and gain better data visibility in order to accelerate their 2125...

Medidata Edge Strategic Monitoring Wins "Best Sponsor-Focused Technological Development" At CARE Awards 2018

Medidata Edge Strategic Monitoring Wins "Best Sponsor-Focused Technological Development" At CARE Awards 2018

Medidata (NASDAQ: MDSO) is pleased to announce that its risk based monitoring solution, Edge Strategic Monitoring, won an Informa Clinical and Research Excellence (CARE) Award, marking the third consecutive year the company earned this distinction.

Life Science Leaders Discuss Future Of Drug Development At Medidata NEXT London

Life Science Leaders Discuss Future Of Drug Development At Medidata NEXT London

Medidata (NASDAQ: MDSO) is hosting the final European NEXT conference in London this week, with executives presenting from Novartis, aparito, and the global life sciences community.

Medidata Reports First Quarter 2018 Results

Medidata Reports First Quarter 2018 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the first quarter of 2018.

TheStreet Quant Rating: B (Buy)